MHC ligands and peptide motifs: first listing
Tóm tắt
Từ khóa
Tài liệu tham khảo
Achour, A., Picard, O., Zagury, D., Sarin, P. S., Gallo, R. C., Nagler, P. H., and Goldstein, A. L. HGP-30, a synthetic analog of human immunodeficiency virus (HIV) (p17), is a target for cytotoxic T lymphocytes in HIV-infected individuals. Proc Natl Acad Sci USA 87: 7045–7049, 1990
Alsheiklhy, A. R. Interaction of in vitro- and in vivo-generated cytotoxic T Cells with SV40 T antigen — analysis with synthetic peptides. Scand J Immunol 39: 467–479, 1994
Altuvia, Y., Berzofsky, J. A., Rosenfeld, R., and Margalit, H. Sequence features that correlate with MHC restriction. Mol Immunol 31: 1–19, 1994
Anderson, D. C., van Schoten, W. C. A., Barry, M. E., Janson, A. A. M., Buchanan, T. M., and De Vries, R. R. P. A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide. Science 242: 259, 1988
Banks, T. A., Nair, S., and Rouse, B. T. Recognition by and in vitro induction of cytotoxic T-lymphocytes against predicted epitopes of the immediate-early protein-ICP27 of Herpes-Simplex virus. J Virol 67: 613–616, 1993
Bastin, J., Rothbard, J., Davey, J., Jones, I., and Townsend, A. Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. J Exp Med 165: 1508–1523, 1987
Beauverger, P., Buckland, R., and Wild, T. F. Measles-virus antigens induce both type-specific and canine-distemper virus cross-reactive cytotoxic T-lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope. J Gen Virol 74: 2357–2363, 1993
Beauverger, P., Buckland, R., and Wild, F. Measles hemagglutinin induces an Ld-restricted CD8+ cytotoxic T lymphocyte response to two specific epitopes. Virology 200: 281–283, 1994
Bednarek, M. A., Sauma, S. Y., Gammon, M. C., Porter, G., Tamhankar, S., Williamson, A. R., and Zweerink, H. J. The minimum peptide epitope from the influenza matrix protein. Extra and intracellular loading of HLA-A2. J Immunol 147: 4047–4053, 1991
Bergmann, C., McMillan, M., and Stohlman, S. Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis-virus nucleocapsid protein. J Virol 67: 7041–7049, 1993a
Bergmann, C., Stohlmann, S. A., and McMillan, M. An endogenously synthesized decamer peptide efficiently primes cytotoxic T-cells specific for the HIV-1 envelope glycoprotein. Eur J Immunol 23: 2777–2781, 1993b
Bertoletti, A., Chisari, F. V., Penna, A., Guilhot, S., Galati, L., Missale, G., Fowler, P., Schlicht, H. J., Vitiello, A., Chesnut, R. C., Fiaccadori, F., and Ferrari, C. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis-B virus nucleocapsid protein. J Virol 67: 2376–2380, 1993
Bertoletti, A., Costanzo, A., Chisari, F. V., Levrero, M., Artini, M., Sette, A., Penna, A., Giuberti, T., Fiaccadori, F., and Ferrari, C. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180: 933–943, 1994
Blum-Tirouvanziam, U., Beghdadi-Rais, C., Roggero, M. A., Valmori, D., Bertholet, S., Bron, C., Fasel, N., and Corradin, G. Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides. J Immunol 153: 4134–4141, 1994
Bodmer, J. G., Marsh, S. G. E., Albert, E. D., Bodmer, W. F., Dupont, B., Erlich, H. A., Mach, B., Mayr, W. R., Parham, P., Sasazuki, T., Schreuder, G. M. T., Strominger, J. L., Svejgaard, A., and Terasaki, P. I. Nomenclature for factors of the HLA system, 1994. Tissue Antigens 44: 1–18, 1994
Bogen, B., Snodgrass, R., Briand, J. P., and Hannestad, K. Synthetic peptides and beta-chain gene rearrangement reveal a diversified T cell repertoire for a lambda light chain third hypervariable region. Eur J Immmunol 16: 1379–1384, 1986
Bonneau, R. H., Salvucci, L. A., Johnson, D. C., and Tevethia, S. S. Epitope specificity of H-2Kb-restricted, HSV-1-cross-reactive, and HSV-2-cross-reactive cytotoxic T-lymphocyte clones. Virology 195: 62–70, 1993
Braciale, T. J., Braciale, V. L., Winkler, M., Stroynowski, I., Hood, L., Sambrook, J., and Gething, M.-J. On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolic T lymphocytes. J Exp Med 166: 678–692, 1987
Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T-lymphocytes on HLA-A2 melanomas. J Exp Med 178: 489–495, 1993
Brooks, J. M., Murray, R. J., Thomas, W. A., Kurilla, M. G., and Rickinson, A. B. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J Exp Med 178: 879–887, 1993
Brown, E. L., Wooters, J. L., Ferenz, C. R., O'Brien, C. M., Hewick, R. M., and Herrmann, S. H. Characterization of peptide binding to the murine MHC class I H-2Kk molecule — sequencing of the bound peptides and direct binding of synthetic peptides to isolated class I molecules. J Immunol 153: 3079–3092, 1994
Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., and Wiley, D. C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33–39, 1993
Burrows, S. R., Sculley, T. B., Misko, I. S., Schmidt, C., and Moss, D. J. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). J Exp Med 171: 345–349, 1990
Buseyne, F., McChesney, M., Porrot, F., Kovarik, S., Guy, B., and Riviere, Y. Gag-specific cytotoxic T-lymphocytes from human-immunodeficiency-virus type-1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein. J Virol 67: 694–702, 1993
Buseyne, F. and Riviere, Y. HIV-specific CD8+T-cell immune reponses and viral replication. Aids 7: S81-S85, 1993
Buus, S.,Sette, A., Colon, S. M., Miles, C., and Grey, H. M. The relation between major histocompatibility comples (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 235: 1353–1358, 1987
Cao, W. X., Myers-Powell, B. A., and Braciale, T. J. Recognition of an immunoglobulin Vh epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes. J Exp Med 179: 195–202, 1994
Carbone, F. R., Moore, M. W., Sheil, J. M., and Bevan, M. J. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. J Exp Med 167: 1767–1779, 1988
Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., and Serra, H. M. Induction of antitumor cytotoxic T-lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci USA 91: 2105–2109, 1994
Cerrone, M. C., Ma, J. J., and Stephens, R. S. Cloning and sequence of the gene for heat-shock protein-60 from Chlamydia trachomatis and immunological reactivity of the protein. Infect Immun 59: 79–90, 1991
Cerundo, V., Elliot, T., Elvin, J., Bastin, J., Rammensee, H.-G., and Townsend, A. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules. Eur J Immunol 21: 2069–2075, 1991
Chicz, R. M., Urban, R. G., Lane, W. S., Gorga, J. C., Stern, L. J., Vignali, D. A. A., and Strominger, J. L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358: 764–768, 1992
Chicz, R. M., Urban, R. G., Gorga, J. C., Vigali, D. A. A., Lane, W. S., and Strominger, J. L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178: 27–47, 1993
Corr, M., Boyd, L. F., Frankel, S. R., Kozlowski, S., Padlan, E. A., and Margulies, D. H. Endogenous peptides of a soluble major histocompatibility complex class-I molecule, H-2Lds-sequence motif, quantitative binding, and molecular modeling of the complex. J Exp Med 176: 1681–1692, 1992
Corr, M., Boyd, L. F., Padlan, E. A., and Margulies, D. H. H-2Dd exploits a 4 residue peptide binding motif. J Exp Med 178: 1877–1892, 1993
Cossins, J., Gould, K. G., Smith, M., Driscoll, P., and Brownlee, G. G. Precise prediction of a Kk-restricted cytotoxic T-cell epitope in the NS1 protein of influenza-virus using an MHC allele-specific motif. Virology 193: 289–295, 1993
Coulie, P. G., Brichard, V., Van Pel, A., Wölel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., Renauld, J. C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T-lymphocytes on HLA-A2 melanomas. J Exp Med 180: 35–42, 1994
Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Slingluff, C. L. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264: 716–719, 1994
Cresswell, P. Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 12: 259–293, 1994
Culmann, B., Gomard, E., Kieny, M. P., Guy, B., Dreyfus, F., Saimot, A. G., Sereni, D., Sicard, D., and Levy, J. P. 6 epitopes reacting with human cytotoxic CD8+ T-cells in the central region of the HIV-1 nef protein. J Immunol 146: 1560–1565, 1991
Dai, L. C., West, K., Littaua, R., Takahashi, K., and Ennis, F. A. Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes. J Virol 66: 3151–3154, 1992
De Bergeyck, V., De Plaen, E., Chomez, P., Boon, T., and Van Pel, A. An inttracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia. Eur J Immunol 24: 2203–2212, 1994
Deckhut, A. M., Lippolis, J. D., and Tevethia, S. S. Comparative analysis of core amino-acid-residues of H-2Db-restricted cytotoxic T-lymphocyte recognition epitopes in Simian virus 40 T antigen. J Virol 66: 440–447, 1992
DiBrino, M., Parker, K. C., Shiloach, J., Knierman, M., Lukszo, J., Turner, R. V., Biddison, W. E., and Coligan, J. E. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc Natl Acad Sci USA 90: 1508–1512, 1993a
DiBrino, M., Tsuchida, T., Turner, R. V., Parker, K. C., Coligan, J. E., and Biddison, W. E. HLA-A1 and HLA-A3 T-cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J Immunol 151: 5930–5935, 1993b
DiBrino, M., Parker, K. C., Shiloach, J., Turner, R. V., Tsuchida, T., Garfield, M., Baddison, W. E., and Coligan, J. E. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8. J Immunol 152: 620–631, 1994
Dick, L. R., Aldrich, C., Jameson, S. C, Moomaw, C. R., Pramanik, B. C., Doyle, C. K., Demartino, G. N., Bevan, M. J., Forman, J. M., and Slaughter, C. A. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to yield antigenic peptides. J Immunol 152: 3884–3894, 1994
Eberl, G., Sabbatini, A., Servis, C., Romero, P., Maryanski, J. L., and Corradin, G. MHC class I H-2Kd-restricted antigenic peptides: additional constraints for the binding motif. Int Immunol 5: 1489–1492, 1993
Engelhard, V. H., Appella, E., Benjamin, D. C., Bodnar, W. M., Cox, A. L., Chen, Y., Henderson, R. A., Huczko, E. L., Michel, H., Sakaguichi, K., Shabanowitz, J., Sevilir, N., Slingluff, C. L., and Hunt, D. F. Mass spectrometric analysis of peptides associated with the human class-I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding. In A. Sette (ed.): Naturally Processed Peptides, Karger, pp. 39–62, 1993
Engelhard, V. H. Structure of peptides associated with MHC class I molecules. Curr Opin Immunol 6: 13–23, 1994
Falk, K., Rötzschke, O., and Rammensee, H.-G. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348: 248–251, 1990
Falk, K., Rötzschke, O., Deres, K., Metzger, J., Jung, G., and Rammensee, H.-G. Identification of naturally processed viral non-apeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J Exp Med 174: 425–434, 1991a
Falk, K., Rötzschke, O., Stevanović, S., Jung, G., and Rammensee, H.-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290–296, 1991b
Falk, K., Rötzschke, O., Grahovac, B., Schendel, D., Stevanović, S., Gnau, V., Jung, G., Strominger, J. L., and Rammensee, H.-G. Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci USA 90: 12005–12009, 1993a
Falk, K., Rötzschke, O., Grahovac, B., Schendel, D., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-B35 and HLA-B37 molecules. Immunogenetics 38: 161–162, 1993b
Falk, K., Rötzschke, O., Stevanović, S., Gnau, V., Sparbier, K., Jung, G., Rammensee, H.-G., and Walden, P. Analysis of a naturally occuring HLA class I-restricted viral epitope. Immunology 82: 337–342, 1994a
Falk, K., Rötzschke, O., Stevanović, S., Jung, G., and Rammensee, H.-G. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39: 230–242, 1994b
Falk, K., Rötzschke, O., Takiguchi, M., Grahovac, B., Gnau, V., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules. Immunogenetics 40: 238–241, 1994c
Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-B51, -B52, and-B78 molecules and implications for Behçet's disease. Int Immunol 7: 223–228, 1995a
Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-B38 and B39 molecules. Immunogenetics 41: 162–164, 1995b
Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-B58, B60, B61, and B62 molecules. Immunogenetics 41: 165–168, 1995c
Falk, K. and Rötzschke, O. Consensus motifs and peptide ligands of MHC class I molecules. Sem Immunol 5: 81–94, 1993
Feltkamp, M. C. W., Smith, H. L., Vierboom, M. P. M., Minnaar, R. P., Dejongh, B. M., Drijfhout, J. W., Terschegget, J., Melief, C. J. M., and Kast, W. M. Vaccination with cytotoxic T-lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type-16-transformed cells. Eur J Immunol 23: 2242–2249, 1993
Fischer Lindahl, K. F., Hermel, E., Loveland, B. E., and Wang, C. R. Maternally transmitted antigen of mice — a model transplantation antigen. Annu Rev Immunol 9: 351–372, 1991
Fleischhauer, K., Wallny, H.-J., Avila, D., Vilbois, F., Traversari, C., and Bordignon, C. Characterization of natural peptide ligands for HLA-B44. Tissue Antigens, in press
Franco, M. A., Prieto, I., Labbe, M., Poncet, D., Borras-Cuesta, F., and Cohen, J. An immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide. J Gen Virol 74: 2579–2586, 1993
Franco, M. A., Lefevre, P., Willems, P., Lintermanns, P., Tosser, G., and Cohen, J. Identification of cytotoxic T cell epitopes on the Vp3 and Vp6 rotavirus proteins. J Gen Virol 75: 589–596, 1994
Fremont, D. H., Matsamura, M., Stura, E. A., Peterson, P. A., and Wilson, I. A. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 257: 919–927, 1992
Frumento, G., Harris, P. E., Gawinowicz, M. A., Suciu-Foca, N., and Pernis, B. Sequence of a prominent 16-residue self-peptide bound to HLA-B27 in a lymphoblastoid cell line. Cell Immunol 152: 623–626, 1993
Gaugler, B., Van den Eynde, B., Van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. J Exp Med 179: 921–930, 1994
Gavin, M. A., Gilbert, M. J., Riddell, S. R., Greenberg, P. D., and Bevan, M. J. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class-I MHC-restricted CTL epitopes. J Immunol 151: 3971–3980, 1993
Gavioli, R., Kurilla, M. G., De Campos-Lima, P. O., Wallace, L. E., Dolcetti, R., Murray, R. J., Rickinson, A. B., and Masucci, M. G. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogeneticities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol 67: 1572–1578, 1993
Geluk, A., Van Meijgaarden, K. E., Janson, A. A. M., Drijfhout, J. W., Meloen, R. H., De Vries, R. R. P., and Ottenhoff, T. H. M. Functional analysis of DR17(DR3)-restricted mycobacterial T-cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J Immunol 149: 2864–2871, 1992
Geluk, A., Van Meijgaarden, K. E., Southwood, S., Oseroff, C., Drijfhout, J. W., De Vries, R. R. P., Ottenhoff, T. H. M., and Sette, A. HLA-DR3 molecules can bind peptides carrying two alternative specific submotifss. J Immunol 152: 5742–5748, 1994
Gotch, F., McMichael, A., and Rothbard, J. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site. J Exp Med 168: 2045–2057, 1988
Gould, K., Cossins, J., Bastin, J., Brownlee, G. G., and Townsend, A. A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes. J Exp Med 170: 1051–1056, 1989
Gould, K. G., Scotney, H., Townsend, A. R., Bastin, J., and Brownlee, G. G. Mouse H-2k-restricted cytotoxic T cells recognize antigenic determinants in both the HA1 and HA2 subunits of the influenza A/PR/8/34 hemagglutinin. J Exp Med 166: 693–701, 1987
Gould, K. G., Scotney, H., and Brownlee, G. G. Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the Influenza A/PR/8/34 virus hemagglutinin. J Virol 65: 5401–5409, 1991
Gregersen, P. K., Silver, J., and Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30: 1205–1213, 1987
Guo, H. C., Jardetzky, T. S., Garrett, T. P. J., Lane, W. S., Strominger, J. L., and Wiley, D. C. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360: 364–366, 1992
Guo, H. C., Madden, D. R., Silver, M. L., Jardetzky, T. S., Gorga, J. C., Strominger, J. L., and Wiley, D. C. Comparison of the P2 specificity pocket in three human histocompatibility antigens — HLA-A*6801, HLA-A*0201, and HLA-B*2705. Proc Natl Acad Sci USA 90: 8053–8057, 1993
Hammer, J., Takacs, B., and Sinigaglia, F. Identification of motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med 176: 1007–1013, 1992
Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B., and Sinigaglia, F. Promiscuos and allele-specific anchors in HLA-DR-binding peptides. Cell 74: 197–203, 1993
Hammer, J., Bono, E., Gallazzi, F., Belunis, C., Nagy, Z., and Sinigaglia, F. Precise prediction of MHC class II-peptide interaction based on peptide side chain scanning. J Exp Med 180: 2353–2358, 1994
Harpur, A. G., Ziemiekci, A., Wilks, A. F., Falk, K., Rötzschke, O., and Rammensee, H.-G. A prominent natural H-2Kd ligand is derived from protein-tyrosine kinase JAK1. Immunol Lett 35: 235–238, 1993
Harris, P. E., Colovai, A., Liu, Z., Favera, R. D., and Suciu-Foca, N. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs. J Immunol 151: 5966–5974, 1993
Henderson, R. A., Michel, H., Sakaguchi, K., Shabanowitz, J., Appella, E., Hunt, D. F., and Engelhard, V. H. HLA-A2.1-associated peptides from a mutant cell line — a 2nd pathway of antigen presentation. Science 255: 1264–1266, 1992
Henderson, R. A., Cox, A. L., Sakaguchi, K., Appella, E., Shabanowitz, J., Hunt, D. F., and Engelhard, V. H. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells. Proc Natl Acad Sci USA 90: 10275–10279, 1993
Hill, A. V. S., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E. M., Gotch, F. M., Gao, X. M., Takiguchi, M., Greenwood, B. M., Townsend, A. R. M., McMichael, A. J., and Whittle, H. C. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360: 434–439, 1992
Hill, C. M., Liu, A., Marshall, K. W., Mayer, J., Jorgensen, B., Yuan, B., Cubbon, R. M., Nichols, E. A., Wicker, L. S., and Rothbard, J. B. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J Immunol 152: 2890–2898 1994
Hosmalin, A., Clerici, M., Houghten, R., Pendleton, C. D., Felxner, C., Lucey, D. R., Moss, B., Germain, R. N., Shearer, G. M., and Berzofsky, J. A. An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proc Natl Acad Sci USA 87: 2344–2348, 1990
Howard, J. C. and Seelig, A. Antigen-processing — peptides and the proteasome. Nature 365: 211–212, 1993
Huczko, E. L., Bodnar, W. M., Benjamin, D., Sakaguchi, K., Zhu, N. Z., Shabanowitz, J., Henderson, R. A., Appella, E., Hunt, D. F., and Engelhard, V. H. Characteristics of endogenous peptides eluted from the class-I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol 151: 2572–2587, 1993
Huet, S., Nixon, D. F., Rothbard, J. B., Townsend, A., Ellis, S. A., and McMichael, A. J. Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27. Int Immunol 2: 311–316, 1990
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., and Engelhard, V. H. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255: 1261–1263, 1992a
Hunt, D. F., Michel, H., Dickinson, T. A., Shabanowitz, J., Cox, A. L., Sakaguchi, K., Appella, E., Grey, H. M., and Sette, A. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 256: 1817–1820, 1992b
Jackson, M. R., Cohendoyle, M. F., Peterson, P. A., and Williams, D. B. Regulation of MHC class-I transport by the molecular chaperone, calnexin (P88, IP90). Science 263: 384–387, 1994
Jackson, M. R. and Peterson, P. A. Assembly and intracellular transport of MHC class-I molecules. Annu Rev Cell Biol 9: 207–235, 1993
Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., and Wiley, D. C. Identification of self peptides bound to purified HLA-B27. Nature 353: 326–329, 1991
Johnson, R. P., Trocha, A., Buchanan, T. M., and Walker, B. D. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp 120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. J Virol 67: 438–445, 1993
Joyce, S., Tabaczewski, P., Angeletti, R. H., Nathenson, S. G., and Stroynowski, I. A nonpolymorphic major histocompatibility complex class I b molecule binds a large array of diverse self-peptides. J Exp Med 179: 579–588, 1994
Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Meloen, R. H., Van der Eb, A. J., and Melief, C. J. M. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59: 603–614, 1989
Kast, W. M., Roux, L., Curren, L., Blom, H. J. J., Voordouw, A. C., Meloen, R. H., Kolakofsky, D., and Melief, C. J. M. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide Proc Natl Acad Sci USA 88: 2283–2287, 1991
Kast, W. M., Brandt, R. M. P., Sidney, J., Drijfhout, J. W., Kubo, R. T., Grey, H. M., Melief, C. J. M., and Sette, A. Role of HLA-A motifs in identification of potential CTL epitopes in human papiloomavirus type 16 E6 and E7 proteins. J Immunol 152: 3904–3912, 1994
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human-melanoma antigen recognized by autologous T-cells infiltrating into tumor. Proc Natl Acad Sci USA 91: 3515–3519, 1994a
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human-melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91: 6458–6462, 1994b
Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Identification of ane immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180: 347–352, 1994c
Khalil, I., D'Auriol, L., Gobet, M., Morin, L., Lepage, V., Deschamps, I., Park, M. S., Degos, L., Galibert, F., and Hors, J. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85: 1315–1319, 1990
Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E., and Moss, D. J. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 176: 169–176, 1992
Kinouchi, R., Kobayashi, H., Sato, K., Kimura, S., and Katagiri, M. Peptide motifs of HLA-DR4/DR53 (DRB1*0405/DRB4*0101) molecules. Immunogenetics 40: 376–378, 1994
Klavinskis, L. S., Whitton, J. L., Joly, E., and Oldstone, M. B. A. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178: 393–400, 1990
Klein, J. Natural History of the Major Histocompatibility Complex, J. Wiley & Sons, New York, 1986
Koenig, S., Fuerst, T. R., Wood, L. V., Woods, R. M., Suzich, J. A., Jones, G. M., De la Cruz, V. F., Davey, R. T. Jr., Venkatesan, S., Moss, B., Biddison, W. E., and Fauci, A. S. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J Immunol 145: 127–135, 1990
Koziel, M. J., Dudley, D., Wong, J. T., Dienstag, J., Houghton, M., Ralston, R., and Walker, B. D. Intrahepatic cytotoxic T-lymphocytes specific for hepatitis-C virus in persons with chronic hepatitis. J Immunol 149: 3339–3344, 1992
Kropshofer, H., Max, H., Müller, C. A., Hesse, F., Stevanović, S., Jung, G., and Kalbacher, H. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J Exp Med 175: 1799–1803, 1992
Kropshofer, H., Max, H., Halder, T., Kalbus, M., Müller, C. A., and Kalbacher, H. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming. J Immunol 151: 4732–4742, 1993
Kubo, R. T., Sette, A., Grey, H. M., Appella, E., Sakaguchi, K., Zhu, N. Z., Arnott, D., Sherman, N., Shabanowitz, J., Michel, H., Bodnar, W. M., Davis, T. A., and Hunt, D. F. Definition of specific peptide motifs for four major HLA-A alleles. J Immunol 152: 3913–3924, 1994
Kulkarni, A. B., Morse, III, H. C., Bennink, J. R., Yewdell, J. W., and Murphy, B. R. Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic-T cells. J Virol 67: 4086–4092, 1993
Kumar, S., Miller, L. H., Quakyi, I. A., Keister, D. B., Houghten, R. A. Maloy, W. L., Moss, B., Berzofsky, J. A., and Good, M. F. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature 334: 258–260, 1988
Kutubuddin, M., Simons, J., and Chow, M. Poliovirus-specific major histocompatibility complex class-I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions. J Virol 66: 5967–5974, 1992
Kuwano, K., Braciale, T. J., and Ennis, F. A. Localization of a cross-reactive CTL epitope to the transmembrane region of the hemagglutinin of influenza H1 and H2 viruses. FASEB J 2: 2221, 1988
Larson, J. K., Wunner, W. H., Otvos, Jr., L., and Ertl, H. C. Identification of an immunodominant epitope within the phosphoprotein of rabies virus that is recognized by both class I- and class II-restricted T cells. J Virol 65: 5673–5679, 1991
Lee, S. P., Thomas, S. A., Murray, R. J., Khanim, F., Faur, S., Young, L. S., Rowe, M., Kurilla, M., and Rickinson, A. B. HLA A2.1-restricted cytotoxic T-cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol 67: 7428–7435, 1993
Lethé, B., Van den Eynde, B., Van Pel, A., Corradin, G., and Boon, T. Mouse tumor rejection antigens P815A and antigen P815B: 2 epitopes carried by a single peptide. Eur J Immunol 22: 2283–2288, 1992
Littua, R. A., Oldstone, M. B. A., Takeda, A., Debouck, C., Wong, J. T., Tuazon, C. U., Moss, B., Kievits, F., and Ennis, F. A. An HLA-C restricted CD8+ cytotoxic T lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol 65: 4051–4056, 1991
Lurquin, C., Van Pel, A., Mariamé, B., De Plaen, E., Szikora, J.-P., Janssens, C., Reddehase, M. J., Lejeune, J., and Boon, T. Structure of the gene of tum-transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells. Cell 58: 293–303, 1989
Madden, D. R., Garboczi, D. N., and Wiley, D. C. The antigenic identify of peptide-MHC complexes — a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75: 693–708, 1993
Maier, R., Falk, K., Rötzschke, O., Maier, B., Gnau, V., Stevanović, S., Jung, G., Rammensee, H.-G., and Meyerhans, A. Peptide motifs of HLA-A3,-A24, and-B7 molecules as determined by pool sequencing. Immunogenetics 40: 306–308, 1994
Malcherek, G., Falk, K., Rötzschke, O., Rammensee, H.-G., Stevanović, S., Gnau, V., Jung, G., and Melms, A. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int Immunol 5: 1229–1237, 1993
Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Einstein, M., and Eisenbach, L. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung-carcinoma. Nature 369: 67–71, 1994
Marrack, P., Ignatowicz, L., Kappler, J. W., Boymel, J., and Freed, J. H. Comparison of peptides bound to spleen and thymus class-II. J Exp Med 178: 2173–2183, 1993
Martin, R., Howell, M. D., Jaraquemada, D., Flerlage, M., Richert, J., Brostoff, S., Long, E. O., McFarlin, D. E., and McFarland, H. F. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 173: 19–24, 1991
Maryanski, J. L., Pala, P., Corradin, G., Jordan, B. R., and Cerottini, J.-C. H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature 324: 578–579, 1986
Matsushita, S., Takahashi, K., Motoki, M., Komoriya, K., Ikagawa, S., and Nishimura, Y. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and-DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 180: 873–883, 1994
Missale, G., Redeker, A., Person, J., Fowler, P., Guilhot, S., Schlicht, H. J., Ferrari, C., and Chisari, F. V. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 177: 751–762, 1993
Momburg, F., Neefjes, J. J., and Hämmerling, G. J. Peptide selection by MHC-encoded Tap transporters. Curr Opin Immunol 6: 32–37, 1994
Nayersina, R., Fowler, P., Guilhot, S., Missale, G., Cerny, A., Schlicht, H. J., Vitiello, A., Chesnut, R., Person, J. L., Redeker, A. G., and Chisari, F. V. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 150: 4659–4671, 1993
Neefjes, J. J. and Momburg, F. Cell biology of antigen presentation. Curr Opin Immunol 5: 27–34, 1993
Nelson, C. A., Roof, R. W., McCourt, D. W., and Unanue, E. R. Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. Proc Natl Acad Sci USA 89: 7380–7383, 1992
Newcomb, J. R. and Cresswell, P. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha-beta-dimers. J Immunol 150: 499–507, 1993
Norda, M., Falk, K., Rötzschke, O., Stevanović, S., Jung, G., and Rammensee, H.-G. Comparison of the H-2Kk and H-2Kkml restricted peptide motifs. J Immunother 14: 144–149, 1993
O'Sullivan, D., Arrhenius, T., Sidney, J., Del Guercio, M.-F., Albertson, M., Wall, M., Oseroff, C., Southwood, S., Colon, S. M., Gaeta, F. C. A. and Sette, A. On the interaction of promiscuos antigenic peptides with different DR alleles. Identification of common structural motifs. J Immunol 147: 2663–2669, 1991
Oldstone, M. B. A., Whitton, J. L., Lewicki, H., and Tishon, A. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes. J Exp Med 168: 559–570, 1988
Oldstone, M. B. A., Tishon, A., Eddleston, M., De La Torre, J. C., McKee, T., and Whitton, J. L. Vaccination to prevent persistent viral infection. J Virol 67: 4372–4378, 1993
Ortmann, B., Androlewicz, M. J., and Cresswell, P. MHC class I beta2-microglobulin complexes associate with Tap transporters before peptide binding. Nature 368: 364–867, 1994
Pamer, E. G., Harty, J. T., and Bevan, M. J. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353: 852–855, 1991
Pamer, E. G. Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope. J Immunol 152: 686–694, 1994
Parker, K. C., Bednarek, M. A., and Coligan, J. E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152: 163–175, 1994
Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., and Harding, C. V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361: 359–362, 1993
Phillips, R. E., Rowland-Jones, S., Huet, S., Hill, A., Sutton, J., Murray, R., Brooks, J., and McMichael, A. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453–459, 1991
Pinet, V., Malnati, M. S., and Long, E. O. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J Immunol 152: 4852–4860, 1994
Rammensee, H.-G., Falk, K., and Rötzschke, O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11: 213–244, 1993
Rawle, F. C., O'Connell, K. A., Geib, R. W., Roberts, B., and Gooding, L. R. Fine mapping of an H-2Kk restricted cytotoxic T lymphocyte epitope in SV 40 T antigen by using in-frame deletion mutants and a synthetic peptide. J Immunol 141: 2734–2739, 1988
Reay, P. A., Kantor, R. M., and Davis, M. M. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome C (93–103). J Immunol 152: 3946–3957, 1994
Reddehase, M. J., Rothbard, J. B., and Koszinowski, U. H. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337: 651–653, 1989
Reich, E. P., Von Grafenstein, H., Barlow, A., Swenson, K. E., Williams, K., and Janeway, C. A. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J Immunol 152: 2279–2288, 1994
Riberdy, J. M., Newcomb, J. R., Surman, M. J., Barbosa, J. A., and Cresswell, P. HLA-DR molecules from an antigen-processing mutant-cell line are associated with invariant chain peptides. Nature 360: 474–477, 1992
Robbins, P. A., Lettice, L. A., Rota, P., Santos-Aguado, J., Rothbard, J., McMichael, A. J., and Strominger, J. L. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations withinn HLA-A2. J Immunol 143: 4098–4103, 1989
Robbins, P. F., Elgamil, M., Kawakami, Y., and Rosenberg, S. A. Recognition of tyrosinaee by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 54: 3124–3126, 1994
Rock, K. L., Rohhstein, L., Gamble, S., and Fleischacker, C. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J Immunol 150: 438–446, 1993
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761–771, 1994
Romero, P., Maryanski, J. L., Corradin, G., Nussenzweig, R. S., Nussenzweig, V., and Zavala, F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341: 323–326, 1989
Romero, P., Corradin, G., Leuscher, I. F., and Maryanski, J. L. H-2Kd-restricted antigenic peptides share a simple binding motif. J Exp M Med 174: 603–612, 1991
Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Jung, G., and Rammensee, H.-G. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348: 252–254, 1990
Rötzschke, O., Falk, K., Stevanović, S., Jung, G., Walden, P., and Rammensee, H.-G. Exact prediction of a natural T cell epitope. Eur J Immunol 21: 2891–2894, 1991
Rötzschke, O., Falk, K., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of closely related HLA class I molecules encompass substantial differences. Eur J Immunol 22: 2453–2456, 1992
Rötzschke, O., Falk, K., Stevanović, S., Grahovac, B., Soloski, M. J., Jung, G., and Rammensee, H.-G. Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules. Nature 361: 642–644, 1993
Rötzschke, O., Falk, K., Stevanović, S., Gnau, V., Jung, C., and Rammensee, H.-G. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 39: 74–77, 1994
Rötzschke, O. and Falk, K. Origin, structure and motifs of naturally processed MHC class II ligands. Curr Opin Immunol 6: 45–51, 1994
Rudensky, A. Y., Preston-Hurlburt, P., Hong, S.-C., Barlow, A., and Janeway, C. A. Sequence analysis of peptides bound to MHC class II molecules. Nature 353: 622–627, 1991
Rudensky, A. Y., Preston-Hurlburt, P., Al-Ramadi, B. K., Rothbard, J., and Janeway, C. A. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359: 429–431, 1992
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., and Sette, A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74: 929–937, 1993
Schulz, M., Aichele, P., Schneider, R., Hansen, T. H., Zinkernagel, R. M., and Hengartner, H. Major histocompatibility complex binding and T-cell recognition of a viral nonapeptide containing a minimal tetrapeptide. Eur J Immunol 21: 1181–1185, 1991
Schumacher, T. N., De Bruijin, M. L., Vernie, L. N., Kast, W. M., Melief, C. J. M., Neefjes, J. J., and Ploegh, H. L. Peptide selection by MHC class I molecules. Nature 350: 703–706, 1991
Sette, A., Buus, S., Appella, E., Smith, J. A., Chesnut, R., Miles, C., Colon, S. M., and Grey, H. M. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci USA 86: 3296–3300, 1989
Sette, A., Ceman, S., Kubo, R. T., Sakaguchi, K., Appella, E., Hunt, D. F., Davis, T. A., Michal, H., Shabanowitz, J., Rudersdorf, R., Grey, H. M., and DeMars, R. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258: 1801–1804, 1992
Sette, A., Sidney, J., Oseroff, C., Del Guercio, M. F., Southwood, S., Arrhenius, T., Powell, M. F., Colon, S. M., Gaeta, F. C. A., and Grey, H. M. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J Immunol 151: 3163–3170, 1993
Sette, A., Sidney, J., Del Guercio, M. F., Southwood, S., Ruppert, J., Dahlberg, C., Grey, H. M., and Kubo, R. T. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol Immunol 31: 813–822, 1994
Shawar, S. M., Vyas, J. M., Rodgers, J. R., Cook, R. G., and Rich, R. R. Specialized functions of major histocompatibility class I molecules. II. Hmt binds N-formylated peptides of mitochondrial and procaryotic origin. J Exp Med 174: 941–944, 1991
Shepherd, J. C., Schumacher, T. N. M., Ashton-Rickardt, P. G., Imaeda, S., Ploegh, H. L., Janeway, C. A., and Tonegawa, S. TAP1-dependent peptide translocation in vitro is ATP-dependent and peptide selective. Cell 74: 577–584, 1993
Shirai, M., Okada, H., Nishioka, M., Akatsuka, T., Wychowski, C., Houghten, R., Pendleton, C. D., Feinstone, S. M., and Berzofsky, J. A. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 68: 3334–3342, 1994
Sibille, C., Chomez, P., Wildmann, C., Van Pel, A., De Plaen, E., Maryanski, J. L., De Bergeyck, V., and Boon, T. Structure of the gene of tum- transplantation antigen P198: A point mutation generates a new antigenic peptide. J Exp Med 172: 35–45, 1990
Sijts, A. J. A. M., Ossendorp, F., Mengede, E. A. M., Van den Elsen, P. J., and Melief, C. J. M. Immunodominant mink cell focus inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes. J Immunol 152: 106–116, 1994
Silver, M. L., Guo, H. C., Strominger, J. L., and Wiley, D. C. Atomic structure of a human MHC molecule presenting an influenza-virus peptide. Nature 360: 367–369, 1992
Sinigaglia, F. and Hammer, J. Defining rules for the peptide-MHC class II interaction. Curr Opin Immunol 6: 52–56, 1994
Spouge, J. L., Guy, H. R., Cornette, J. L., Margalit, H., Cease, K., Berzofsky, J. A., and DeLisi, C. Strong conformational propensities enhance T cell antigenicity. J Immunol 138: 204–212, 1987
Srivastava, P. K., Udono, H., Blachere, N. E., and Li, Z. H. Heat-shock proteins transfer peptides during antigen-processing and CTL priming. Immunogenetics 39: 93–98, 1994
Starnbach, M. N. and Bevan, M. J. Cells infected with Yersinia present an epitope to class I MHC-restricted CTL. J Immunol 153: 1603–1612, 1994
Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., and Wiley, D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 215–221, 1994
Stern, L. J. and Wiley, D. C. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2: 245–251, 1994
Stevanović, S. and Rammensee, H.-G. The structure of T cell epitopes. In M. H. V. Van Regenmortel (ed.) Structure of Antigens, in press
Suh, W. K., Cohendoyle, M. F., Früh, K., Wang, K., Peterson, P. A., and Williams, D. B. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264: 1322–1326, 1994
Sutton, J., Rowland-Jones, S., Roseberg, W., Nixon, D., Gotch, F., Gao, X.-M., Murray, N., Spoonas, A., Driscoll, P., Smith, M., Willis, A., and McMichael, A. A sequence pattern for peptides presented to cytotoxic T-lymphocytes by HLA-B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol 23: 447–453, 1993
Sweetser, M. T., Morrison, L. A., Braciale, V. L., and Braciale, T. J. Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells. Nature 342: 180–182, 1989
Szikora, J. P., Van Pel, A., and Boon, T. Tum-mutation P35b generates the MHC-binding site of a new antigenic peptide. Immunogenetics 37: 135–138, 1993
Takahashi, H., Cohen, J., Hosmalin, A., Cease, K. B., Houghton, R., Cornette, J. L., DeLisi, C., Moss, B., Germain, R. N., and Berzofsky, J. A. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci USA 85: 3105, 1988
Takahashi, K., Dai, L. C., Fuerst, T., Biddison, W. E., Earl, P., Moss, B., and Ennis, F. A. Specific lysis of human immunodeficiency virus type 1-infected cells by H HLA-A3.1-restricted CD8 cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein. Proc Natl Acad Sci USA 88: 10277–10281, 1991
Tarpey, I., Stacey, S., Hickling, J., Birley, H. D. L., Renton, A., Mcindoe, A., and Davies, D. H. Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif. Immunology 81: 222–227, 1994
Tevethia, S. S., Lewis, M., Tanaka, Y., Milici, J., Knowles, B., Maloy, W. L., and Anderson, R. Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on Simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants. J Virol 64: 1192–1200, 1990
Todd, J. A., Bell, J. I., and McDevitt, H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599–604, 1987
Townsend, A., Öhlén, C., Bastin, J., Ljunggren, H.-G., Foster, L., and Kärre, K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340: 443–448, 1989
Townsend, A., Öhlen, C., Rogers, M., Edwards, J., Mukherjee, S., and Bastin, J. Source of unique tumour antigens. Nature 371: 662, 1994
Townsend, A. R., Rothbard, J., Gotch, F. M., Bahadur, G., Wraith, D., and McMichael, A. J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959–968, 1986
Traversari, C., Van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176: 1453–1457, 1992
Udaka, K., Tsomides, T. J., and Eisen, H. N. A naturally occuriing peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I protein. Cell 69: 989–998, 1992
Ukaka, K., Tsomides, T. J., Walden, P., Fukusen, N., and Eisen, H. N. A ubiquitous protein is the source of naturally occurring peptides that are recognize by a CD8+ T-cell clone. Proc Natl Acad Sci USA 90: 11272–11276, 1993
Urban, R. G., Chicz, R. M., Lane, W. S., Strominger, J. L., Rehm, A., Kenter, M. J. H., Uytdehaag, F. G. C. M., Ploegh, H., Uchanska-Ziegler, B., and Ziegler, A. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc Natl Acad Sci USA 91: 1534–1538, 1994
Utz, U., Koenig, S., Coligan, J. E., and Biddison, W. E. Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule. J Immunol 149: 214–221, 1992
Van Binnendijk, R. S., Versteeg van Oosten, J. P., Poelen, M. C., Brugghe, H. F., Hoogerhout, P., Osterhaus, A. D., and Uytdehaag, F. G. Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein. J Virol 67: 2276–2284, 1993
Van Bleek, G. M. and Nathenson, S. G. Isolation of an immunodominant viral peptide from the class I H-2Kb molecule. Nature 348: 213–216, 1990
Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T-lymphocytes on a human melanoma. Science 254: 1643–1647, 1991
Vogt, A. B., Kropshofer, H., Kalbacher, H., Kalbus, M., Rammensee, H.-G., Coligan, J. E., and Martin, R. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol 153: 1665–1673, 1994
Walker, B. D., Flexner, C., Birch-Limberger, K., Fisher, L., Paradis, T. J., Aldovini, A., Young, R., Moss, B., and Schooley, R. T. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type. Proc Natl Acad Sci USA 86: 9514–9518, 1989
Wallny, H.-J. Untersuchungen zur Rolle der MHC-Klasse-I-Moleküle bei der Prozessierung von Nobenhistokompatibilitätsantigenen, Dissertation; Universität Tübingen, 1992
Wallny, H.-J., Deres, K., Faath, S., Jung, G., Van Pel, A., Boon, T., and Rammensee, H.-G. Identification and quantification of a naturally presented peptide as recognized by cytotoxic T lymphocytes specific for an immunogenic tumor variant. Int Immunol 4: 1085–1090, 1992
Wei, M. L. and Cresswell, P. HLA-A2 molecules in an antigen processing mutant cell contain signal sequence derived peptides. Nature 356: 443–446, 1992
Weiss, W. R., Mellouk, S., Houghten, R. A., Sedegah, M., Kumar, S., Good, M. F., Berzofsky, J. A., Miller, L. H., and Hoffmann, S. L. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med 171: 763–773, 1990
White, H. D., Roeder, D. A., and Green, W. R. An immunodominant Kb-restricted peptide from the P15E transmembrane protein of endogenous ecotropic murine leukemia-virus (Mulv) Akr623 that restores susceptibility of a tumor line to anti-AKR Gross MULV cytotoxic T-lymphocytes. J Virol 68: 897–904, 1994
Whitton, J. L., Tishon, A., Lewicki, H., Gebhard, J., Cook, T., Salvato, M., Joly, E., and Oldstone, M. B. A. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J Virol 63: 4303–4310, 1989
Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Zum Büschenfelde, K. H. M., and Boon, T. 2 tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T-Lymphocytes. Eur J Immunol 24: 759–764, 1994
Wucherpfennig, K. W., Sette, A., Southwood, S., Oseroff, C., Matsui, M., Strominger, J. L., and Hafler, D. A. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 179: 279–290, 1994
Yanagi, Y., Tishon, A., Lewicki, H., Cubitt, B. A., and Oldstone, M. B. A. Diversity of T cell receptors in virus specific cytotoxic T lymphocytes recognizing 3 distinct viral epitopes restricted by a single major histocompatibility complex molecule. J Virol 66: 2527–2531, 1992
Zhang, Q. J., Gavioli, R., Klein, G., and Masucci, M. G. An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. Proc Natl Acad Sci USA 90: 2217–2221, 1993
Zhang, W., Young, A. C. M., Imarai, M., Nathenson, S. G., and Sacchettini, J. C. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition. Proc Natl Acad Sci USA 89: 8403–8407, 1992